Effect of Coagulation Factor Concentrate Administration on ROTEM® Parameters in Major Trauma

Overview

Journal Scand J Trauma Resusc Emerg Med

Publisher Biomed Central

Specialty Emergency Medicine

Date 2015 Oct 31

PMID 26514413

Citations 15

Authors

Martin Ponschab

Wolfgang Voelckel

Michaela Pavelka

Christoph J Schlimp

Herbert Schochl

Affiliations

Soon will be listed here.

Abstract

Background: Purified coagulation factor concentrates, such as fibrinogen concentrate (FC) and prothrombin complex concentrate (PCC) are increasingly used as haemostatic therapy for trauma-induced coagulopathy (TIC). The impact of FC and PCC administration on ROTEM parameters among patients with TIC has not been adequately investigated.

Methods: In this retrospective observational study, changes to ROTEM parameters, induced by three different therapeutic interventions, were investigated: patients receiving FC only (FC-group); patients treated with FC and PCC (FC + PCC-group) and patients treated with PCC only (PCC-group).

Results: The study population comprised 96 patients who were predominately male (69 [71.9 %]), median age was 45.0 (26.3-60.0) years, and the median injury severity score was 34.0 (25.0-44.5). Administration of FC resulted in a significant reduction of the clotting time (CT) in both the EXTEM and FIBTEM assays but had no effect on INTEM CT. Clot amplitude (CA) increased significantly in the FIBTEM assay but remained unchanged in the EXTEM and INTEM assays. The combined administration of FC and PCC increased FIBTEM maximum clot firmness (MCF) and normalized EXTEM CT but did not change either INTEM or FIBTEM CT. Following PCC therapy, EXTEM and FIBTEM CT normalized; CA at 10 min after CT measurements decreased significantly in EXTEM, INTEM and FIBTEM.

Conclusions: Administration of FC alone or in combination with PCC resulted in a significant improvement of fibrin polymerisation as measured by an increase in FIBTEM MCF. CT is dependent not only on thrombin generation but also on the availability of substrate (fibrinogen). Accelerated fibrin polymerisation rate results in earlier clot formation and consequently shorter CT. PCC administration normalised EXTEM CT below the upper threshold of 80 s. This study was performed at the AUVA Trauma Centre Salzburg, Salzburg, Austria.

Citing Articles

Update on the pathophysiology and management of acute trauma hemorrhage and trauma-induced coagulopathy based upon viscoelastic testing.

Maegele M Clin Exp Emerg Med. 2024; 11(3):259-267.

PMID: 38485260 PMC: 11467455. DOI: 10.15441/ceem.24.202.

The European guideline on management of major bleeding and coagulopathy following trauma: sixth edition.

Rossaint R, Afshari A, Bouillon B, Cerny V, Cimpoesu D, Curry N Crit Care. 2023; 27(1):80.

PMID: 36859355 PMC: 9977110. DOI: 10.1186/s13054-023-04327-7.

Role of prothrombin complex concentrate in the severe trauma patient.

Egea-Guerrero J, Quintana-Diaz M Front Med (Lausanne). 2022; 9:988919.

PMID: 36405577 PMC: 9666687. DOI: 10.3389/fmed.2022.988919.

Coagulopathy management of multiple injured patients - a comprehensive literature review of the European guideline 2019.

Niemann M, Otto E, Eder C, Youssef Y, Kaufner L, Mardian S EFORT Open Rev. 2022; 7(10):710-726.

PMID: 36287131 PMC: 9619392. DOI: 10.1530/EOR-22-0054.

Management of Coagulopathy in Bleeding Patients.

Hofer S, Schlimp C, Casu S, Grouzi E J Clin Med. 2022; 11(1).

PMID: 35011742 PMC: 8745606. DOI: 10.3390/jcm11010001.

References

Senzolo M, Coppell J, Cholongitas E, Riddell A, Triantos C, Perry D . The effects of glycosaminoglycans on coagulation: a thromboelastographic study. Blood Coagul Fibrinolysis. 2007; 18(3):227-36. DOI: 10.1097/MBC.0b013e328010bd3d. View

Bolliger D, Szlam F, Molinaro R, Rahe-Meyer N, Levy J, Tanaka K . Finding the optimal concentration range for fibrinogen replacement after severe haemodilution: an in vitro model. Br J Anaesth. 2009; 102(6):793-9. DOI: 10.1093/bja/aep098. View

Schochl H, Schlimp C . Trauma bleeding management: the concept of goal-directed primary care. Anesth Analg. 2013; 119(5):1064-73. DOI: 10.1213/ANE.0b013e318270a6f7. View

Grassetto A, Fullin G, Cerri G, Simioni P, Spiezia L, Maggiolo C . Management of severe bleeding in a ruptured extrauterine pregnancy: a theragnostic approach. Blood Coagul Fibrinolysis. 2013; 25(2):176-9. DOI: 10.1097/MBC.0000000000000010. View

Ostrowski S, Johansson P . Endothelial glycocalyx degradation induces endogenous heparinization in patients with severe injury and early traumatic coagulopathy. J Trauma Acute Care Surg. 2012; 73(1):60-6. DOI: 10.1097/TA.0b013e31825b5c10. View

David J, Godier A, Dargaud Y, Inaba K . Case scenario: management of trauma-induced coagulopathy in a severe blunt trauma patient. Anesthesiology. 2013; 119(1):191-200. DOI: 10.1097/ALN.0b013e31828fc627. View

Rehm M, Bruegger D, Christ F, Conzen P, Thiel M, Jacob M . Shedding of the endothelial glycocalyx in patients undergoing major vascular surgery with global and regional ischemia. Circulation. 2007; 116(17):1896-906. DOI: 10.1161/CIRCULATIONAHA.106.684852. View

Cotton B, Reddy N, Hatch Q, Lefebvre E, Wade C, Kozar R . Damage control resuscitation is associated with a reduction in resuscitation volumes and improvement in survival in 390 damage control laparotomy patients. Ann Surg. 2011; 254(4):598-605. PMC: 3816774. DOI: 10.1097/SLA.0b013e318230089e. View

Maegele M, Lefering R, Yucel N, Tjardes T, Rixen D, Paffrath T . Early coagulopathy in multiple injury: an analysis from the German Trauma Registry on 8724 patients. Injury. 2007; 38(3):298-304. DOI: 10.1016/j.injury.2006.10.003. View

10.

Becker B, Chappell D, Bruegger D, Annecke T, Jacob M . Therapeutic strategies targeting the endothelial glycocalyx: acute deficits, but great potential. Cardiovasc Res. 2010; 87(2):300-10. DOI: 10.1093/cvr/cvq137. View

11.

Brohi K, Singh J, Heron M, Coats T . Acute traumatic coagulopathy. J Trauma. 2003; 54(6):1127-30. DOI: 10.1097/01.TA.0000069184.82147.06. View

12.

Haas T, Fries D, Tanaka K, Asmis L, Curry N, Schochl H . Usefulness of standard plasma coagulation tests in the management of perioperative coagulopathic bleeding: is there any evidence?. Br J Anaesth. 2014; 114(2):217-24. DOI: 10.1093/bja/aeu303. View

13.

Renne T, Schmaier A, Nickel K, Blomback M, Maas C . In vivo roles of factor XII. Blood. 2012; 120(22):4296-303. PMC: 3507141. DOI: 10.1182/blood-2012-07-292094. View

14.

Kauvar D, Lefering R, Wade C . Impact of hemorrhage on trauma outcome: an overview of epidemiology, clinical presentations, and therapeutic considerations. J Trauma. 2006; 60(6 Suppl):S3-11. DOI: 10.1097/01.ta.0000199961.02677.19. View

15.

Sorensen B, Fries D . Emerging treatment strategies for trauma-induced coagulopathy. Br J Surg. 2012; 99 Suppl 1:40-50. DOI: 10.1002/bjs.7770. View

16.

Kashuk J, Moore E, Wohlauer M, Johnson J, Pezold M, Lawrence J . Initial experiences with point-of-care rapid thrombelastography for management of life-threatening postinjury coagulopathy. Transfusion. 2011; 52(1):23-33. DOI: 10.1111/j.1537-2995.2011.03264.x. View

17.

Schochl H, Voelckel W, Grassetto A, Schlimp C . Practical application of point-of-care coagulation testing to guide treatment decisions in trauma. J Trauma Acute Care Surg. 2013; 74(6):1587-98. DOI: 10.1097/TA.0b013e31828c3171. View

18.

Reitsma S, Slaaf D, Vink H, van Zandvoort M, Oude Egbrink M . The endothelial glycocalyx: composition, functions, and visualization. Pflugers Arch. 2007; 454(3):345-59. PMC: 1915585. DOI: 10.1007/s00424-007-0212-8. View

19.

Shakur H, Roberts I, Bautista R, Caballero J, Coats T, Dewan Y . Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial. Lancet. 2010; 376(9734):23-32. DOI: 10.1016/S0140-6736(10)60835-5. View

20.

Grassetto A, De Nardin M, Ganzerla B, Geremia M, Saggioro D, Serafini E . ROTEM®-guided coagulation factor concentrate therapy in trauma: 2-year experience in Venice, Italy. Crit Care. 2012; 16(3):428. PMC: 3580610. DOI: 10.1186/cc11322. View